ATE207076T1 - Ara-c derivate - Google Patents

Ara-c derivate

Info

Publication number
ATE207076T1
ATE207076T1 AT96926032T AT96926032T ATE207076T1 AT E207076 T1 ATE207076 T1 AT E207076T1 AT 96926032 T AT96926032 T AT 96926032T AT 96926032 T AT96926032 T AT 96926032T AT E207076 T1 ATE207076 T1 AT E207076T1
Authority
AT
Austria
Prior art keywords
ara
derivatives
eicosenoyl
elaidoyl
cis
Prior art date
Application number
AT96926032T
Other languages
English (en)
Inventor
Finn Myhren
Bernt Boerretzen
Are Dalen
Kjell Torgeir Stokke
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Application granted granted Critical
Publication of ATE207076T1 publication Critical patent/ATE207076T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Artificial Filaments (AREA)
AT96926032T 1995-07-25 1996-07-12 Ara-c derivate ATE207076T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515279.9A GB9515279D0 (en) 1995-07-25 1995-07-25 Improved therapeutic agents
PCT/NO1996/000179 WO1997005154A1 (en) 1995-07-25 1996-07-12 Improved therapeutic agents

Publications (1)

Publication Number Publication Date
ATE207076T1 true ATE207076T1 (de) 2001-11-15

Family

ID=10778247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926032T ATE207076T1 (de) 1995-07-25 1996-07-12 Ara-c derivate

Country Status (25)

Country Link
US (2) US6316425B1 (de)
EP (1) EP0842185B1 (de)
JP (2) JP4372227B2 (de)
KR (1) KR100401909B1 (de)
AT (1) ATE207076T1 (de)
AU (1) AU714814B2 (de)
CA (1) CA2227533C (de)
CZ (1) CZ291612B6 (de)
DE (1) DE69616074T2 (de)
DK (1) DK0842185T3 (de)
ES (1) ES2166900T3 (de)
GB (1) GB9515279D0 (de)
HU (1) HU224839B1 (de)
IL (2) IL122942A0 (de)
MX (1) MX9800622A (de)
NO (1) NO313985B1 (de)
NZ (1) NZ313790A (de)
PL (1) PL183601B1 (de)
PT (1) PT842185E (de)
RU (1) RU2165260C2 (de)
SK (1) SK283003B6 (de)
TW (1) TW434251B (de)
UA (1) UA55389C2 (de)
WO (1) WO1997005154A1 (de)
ZA (1) ZA966047B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
JP2001503767A (ja) * 1996-11-12 2001-03-21 メディヴィル・アクチボラグ ヌクレオシド
KR100483256B1 (ko) * 1997-01-24 2005-04-15 콘파마 아에스 젬시타빈 유도체
RU2207573C2 (ru) * 2001-08-27 2003-06-27 Новичков Евгений Владимирович Способ прогнозирования продолжительности жизни больных печеночно-клеточной карциномой
US7393862B2 (en) 2002-05-17 2008-07-01 Celgene Corporation Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
KR20060092242A (ko) * 2003-11-03 2006-08-22 코그니스 아이피 매니지먼트 게엠베하 아실 리보뉴클레오시드 및 아실 데옥시리보뉴클레오시드
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
MX2010003261A (es) * 2007-09-26 2010-08-18 Sinai School Medicine Analogos de azacitidina y usos de los mismos.
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
RU2012125350A (ru) * 2009-11-20 2013-12-27 Клавис Фарма Аса Парентеральные препараты производных гемцитабина
AU2011277183B2 (en) * 2010-07-13 2014-11-13 Clavis Pharma Asa Parenteral formulations of elacytarabine derivatives
KR101770246B1 (ko) * 2012-03-28 2017-08-22 후지필름 가부시키가이샤 1-(2-디옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 염
WO2019136739A1 (en) 2018-01-15 2019-07-18 Yinuoke Medicine Science And Technology Company Ltd. Treatments for cachexia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894000A (en) * 1971-01-27 1975-07-08 Upjohn Co Ara-cytidine derivatives and process of preparation
US4771056A (en) * 1985-08-29 1988-09-13 Roman Rozencwaig Method of medical treatment with serotonin antagonists
FI105556B (fi) 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta
GB2266525A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted cephalosporin sulfone compositions useful in the treatment of leukemia
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
US5641758A (en) 1993-11-10 1997-06-24 Kluge; Michael Cytarabine derivatives, the preparation and use thereof

Also Published As

Publication number Publication date
DE69616074T2 (de) 2002-06-06
JP4372227B2 (ja) 2009-11-25
NO980296L (no) 1998-01-23
NZ313790A (en) 1999-07-29
IL122942A (en) 2006-12-10
PL324690A1 (en) 1998-06-08
AU714814B2 (en) 2000-01-13
GB9515279D0 (en) 1995-09-20
CZ291612B6 (cs) 2003-04-16
IL122942A0 (en) 1999-05-09
NO980296D0 (no) 1998-01-23
ZA966047B (en) 1997-02-04
CA2227533C (en) 2007-01-09
HUP9900924A2 (hu) 2001-05-28
MX9800622A (es) 1998-11-30
SK8098A3 (en) 1998-07-08
KR100401909B1 (ko) 2004-02-14
UA55389C2 (uk) 2003-04-15
EP0842185B1 (de) 2001-10-17
JP2009215326A (ja) 2009-09-24
US6335322B1 (en) 2002-01-01
WO1997005154A1 (en) 1997-02-13
TW434251B (en) 2001-05-16
RU2165260C2 (ru) 2001-04-20
AU6633596A (en) 1997-02-26
EP0842185A1 (de) 1998-05-20
SK283003B6 (sk) 2003-01-09
DK0842185T3 (da) 2002-02-04
PL183601B1 (pl) 2002-06-28
US6316425B1 (en) 2001-11-13
DE69616074D1 (de) 2001-11-22
CZ16398A3 (cs) 1998-06-17
KR19990035804A (ko) 1999-05-25
NO313985B1 (no) 2003-01-13
JP5087052B2 (ja) 2012-11-28
HUP9900924A3 (en) 2001-06-28
JP2002504068A (ja) 2002-02-05
CA2227533A1 (en) 1997-02-13
HU224839B1 (en) 2006-03-28
PT842185E (pt) 2002-04-29
ES2166900T3 (es) 2002-05-01

Similar Documents

Publication Publication Date Title
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
DK0747050T4 (da) Farmaceutiske sammensætninger, der indeholder irbesartan
TR199701567T1 (xx) Rapamisin t�revleri.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
BR9508247A (pt) Derivados de 2-arilciclopentano-2,3-dionas
ID18663A (id) Komposisi farmasi berlapis enterik
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
BR9711586A (pt) Compostos e uso dos mesmo
ATE223431T1 (de) Derivate von dolastatin, dreen herstellung un verwendung
EP0932606A4 (de) Prenyl-transferase inhibitoren
DE69616074D1 (de) Ara-c derivate
DE69603269D1 (de) Derivate von inulin
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
FR2756736B1 (fr) Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
BR9609723A (pt) Derivados da tricetona
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NO965165D0 (no) Anvendelse av 8,9-dehydroestron som en antioksydant
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
DE69611546D1 (de) Herstellung von 2,6-dimethylnaphthalin
ATE223427T1 (de) Modifizierte kojibioside analoge

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0842185

Country of ref document: EP